← The Wire
AAVXFNasdaq
Abivax S.A.
Pharmaceutical Preparations · I0 · CIK 1956827
Abivax develops and commercializes innovative antiviral and anti-inflammatory drugs
44
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
6-K6-KJun 29, 20266-K6-KJun 2, 20266-K6-KMay 22, 20266-K6-KMay 20, 2026SC 13D/ASC 13D/AMay 11, 20266-K6-KMay 7, 20266-K6-KApr 20, 202620-F20-FMar 23, 20266-K6-KMar 23, 20266-K6-KFeb 23, 2026SC 13D/ASC 13D/AJan 14, 20266-K6-KDec 15, 20256-K6-KSep 8, 2025424B5424B5Jul 24, 20256-K6-KJul 24, 2025424B5424B5Jul 23, 20256-K6-KJul 22, 20256-K6-KJun 11, 20256-K6-KJun 2, 20256-K6-KApr 29, 20256-K6-KApr 22, 202520-F20-FMar 24, 20256-K6-KMar 24, 20256-K6-KJan 10, 20256-K6-KDec 23, 20246-K6-KNov 19, 20246-K6-KNov 14, 20246-KFORM 6-KOct 3, 20246-KFORM 6-KOct 3, 20246-KFORM 6-KSep 26, 20246-KFORM 6-KSep 25, 20246-KFORM 6-KSep 9, 20246-K6-KSep 9, 20246-KFORM 6-KAug 6, 20246-KFORM 6-KJul 16, 20246-K6-KJun 4, 20246-KFORM 6-KMay 7, 2024SC 13GSC 13GApr 19, 202420-F20-FApr 5, 20246-KFORM 6-KApr 2, 20246-KFORM 6-KFeb 2, 20246-KFORM 6-KJan 22, 2024SC 13GSC 13GNov 22, 2023SC 13GSC 13GOct 30, 2023SC 13DSC 13DOct 30, 2023424B4424B4Oct 23, 2023
Similar companies
Comparable business profile · signals at a glance